Experimental procedure shows promise for treatment of MS | Longevity science | Scoop.it

An international team of scientists has recently reported success in the first phase of clinical trials in which MS victims’ immune systems were conditioned to become much more tolerant of myelin.\


In the study, white blood cells were obtained from nine MS-afflicted test subjects. These cells were specially processed, coupled with myelin antigens, and then injected intravenously back into their respective donors – up to 3 billion of these dead, treated cells were injected into each person.


When they entered the spleen, which filters dead cells from the bloodstream, both the white blood cells themselves and their myelin antigen payloads were identified by the body as being innocuous. This caused the immune system to become 50 to 75 percent less reactive to myelin, depending on the person and the number of cells injected.